Talampanel for Amyotrophic Lateral Sclerosis

- ALS
- Completed

Study Title: Talampanel for Amyotrophic Lateral Sclerosis (ALS)

Teva Identifier: ALS-TAL-201 (ALSTAR) | ALSTAR

ClinicalTrials.gov Identifier: NCT00696332

Study Status: Completed

Trial Condition(s): ALS

Interventions: Drug: Talampanel | Other: placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Adult, Older Adult

Age Range: 18 Years to 80 Years

Trial Duration: 09/01/2008 - 05/01/2010

Phase: Phase 2

Study Type

Interventional